Rapt Therapeutics Inc is a global biopharmaceutical company focused on discovering and commercialising immune-mediated therapies. It designs and develops therapeutics that aim to tackle unmet medical needs, primarily in cancer and inflammatory diseases.
Based in the biotechnology industry, Rapt Therapeutics Inc uses technology to develop highly selective small molecules that target elusive diseases by modulating critical immune responses. The company has developed a pipeline of drug candidates targeting inflammatory and oncological diseases such as asthma and gastric cancer.
Track the share price of RAPT by adding it to your eToro watchlist.